Startup-071

Startup-071

Düsseldorf, Germany
attyloid offers an ultra-sensitive quantitative technology platform with value-adding potential as biomarker of CNS diseases and drug effect assaying, development and QC of biologicals, and counting of viral particles.

Startup-070

Startup-070

Cambridge, Great Britain
We are developing a market-disruptive technology for cosmetic and therapeutic skin exfoliation/resurfacing by reverse engineering natural processes at a molecular level.

Startup-068

Startup-068

Cologne, Germany
We are developing products that will enable our customers to steer multiple bio-processes in parallel with light. This will enable the large-scale production of new kinds of biopharmaceuticals that are currently in development.